网红黑料

Skip to main content
(352) 733-0111

John A Ligon, MD : Research

Pediatric Hematologist/Oncologist (Child Cancer Specialist)

Photo of John A Ligon
(352) 733-0111 MyUF网红黑料

Research at a glance

Top areas of exploration

  • Neoplasms , 4 publications
  • Cell Line, Tumor , 2 publications
  • Bone Neoplasms , 2 publications
  • Immunocompromised Host , 2 publications

Research activity

38 publications

420 citations

Why is this important?

Active clinical trials

Tinks Trial

The purpose of this study is to determine if the addition of infusions of a type of immune cell called a "natural killer", or NK cell to the sarcoma chemotherapy regimen GEM/DOX (gemcitabine and docetaxel) can improve outcomes in people with鈥�

Investigator
John A Ligon
Status
Accepting Candidates
Ages
2 Years - 40 Years
Sexes
All
OMS721-HCT-002

The purpose of this study is to evaluate the safety and efficacy of narsoplimab in pediatric patients with thrombotic microangiopathies (TMA) following hematopoietic stem cell transplant (HSCT).

Investigator
John A Ligon
Status
Accepting Candidates
Ages
28 Days - 17 Years
Sexes
All

My publications

38 publications

2025

Access to CARe: A Narrative of Real鈥怶orld Medical Decision鈥怣aking to Access Chimeric Antigen Receptor (CAR) T鈥怌ell Therapy in Children, Adolescents, and Young Adults

Pediatric Blood & Cancer

2025

Evolution of the Florida Pediatric Bone Marrow Transplant and Cell Therapy Consortium (FPBCC): A Statewide Initiative Toward Improving Transplant Outcomes

Pediatric Transplantation

鈥�

2025

Revisiting CDKN2A dysregulation in Ewing sarcoma.

Molecular oncology

鈥�

2024

Avatrombopag for severe refractory thrombocytopenia in a pediatric patient with ALL following allogeneic hematopoietic stem cell transplantation: A case report.

Leukemia research reports

鈥�

2024

Cutaneous Lagenidium deciduum infection in a patient with relapsed acute myeloid leukemia.

BMC infectious diseases

鈥�